UPDATE: PTC Therapeutics (PTCT) Gains on Talk Regarding Recommendation of Ataluren
Go back to UPDATE: PTC Therapeutics (PTCT) Gains on Talk Regarding Recommendation of Ataluren| PTC THERAPEUTICS (NASDAQ: PTCT) | Delayed: 24.69 -0.47 (1.87%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $25.16 | 52 Week High | $35.40 | |||
| Open | $25.13 | 52 Week Low | $4.03 | |||
| Day High | $25.28 | P/E | 2.63 | |||
| Day Low | $24.47 | EPS | $9.40 | |||
| Volume | 820,086 | |||||
